$45.42
Value $46.5B
EXC and SRE stock compared: price, dividend, valuation and results, from SEC filings.
$45.42
Value $46.5B
$76.29
Value $49.8B
Exelon (EXC) has a market value of $46.5B and DBA Sempra (SRE) $49.8B. Over the last year, with dividends, EXC moved +0.7% and SRE -14.2%. The P/E is 16.7 for EXC and 22.0 for SRE. Dividend yield: EXC 3.65%, SRE 3.43%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
EXC$46.5B
SRE$49.8B
SRE is 1.1 times EXC
Revenue, 12 months
EXC$25.3B
SRE$12.5B
EXC is 2.0 times SRE
Net income, 12 months
EXC$2.8B
SRE$2.3B
EXC is 1.2 times SRE
Operating margin
EXC20.8%
SRE–
ROIC
EXC5.6%
SRE2.1%
3.5 points apart
P/E
EXC16.7
SRE22.0
SRE is 1.3 times EXC
Dividend yield
EXC3.7%
SRE3.4%
0.3 points apart
5-year return
EXC+41.1%
SRE+45.4%
4.3 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
EXC+41.1%
SRE+45.4%
| Period | EXCWith dividends | SREWith dividends |
|---|---|---|
| 1 year since November 18, 2025 | +0.7%Price -2.1% | -14.2%Price -16.7% |
| 3 years since November 17, 2023 | +29.4%+9.0% a yearPrice +16.6% | +16.0%+5.1% a yearPrice +5.6% |
| 5 years since November 18, 2021 | +41.1%+7.1% a yearPrice +18.9% | +45.4%+7.8% a yearPrice +24.3% |
| 10 years since November 21, 2016 | +175.8%+10.7% a yearPrice +96.0% | +109.6%+7.7% a yearPrice +53.0% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
EXCExelonSREDBA Sempra
| Price | $45.42 | $76.29 |
|---|---|---|
| Market value | $46.5B | $49.8B |
| Enterprise value (EV) | $96.2B | $84.4B |
| P/E | 16.7 | 22.0 |
| P/E, 5-year median | – | 23.3 |
| P/B | 1.6 | 1.5 |
| EV/EBIT | 18.3 | 41.5 |
| Free cash flow yield | – | – |
| Revenue, 12 months | $25.3B | $12.5B |
|---|---|---|
| Net income, 12 months | $2.8B | $2.3B |
| Free cash flow, 12 months | -$1.9B | -$5.2B |
| Earnings per share, 12 months | $2.72 | $3.45 |
| Revenue growth, year on year | 5.3% | 5.1% |
| Revenue growth a year, past | +7.8%over 5 years | +3.8%over 5 years |
| EPS growth a year, past | +7.5%over 5 years | -15.7%over 5 years |
| Gross margin | – | – |
|---|---|---|
| Operating margin | 20.8% | – |
| Net margin | 11.0% | 18.3% |
| ROIC | 5.6% | 2.1% |
| ROE | 9.7% | 7.2% |
| Cash | $1.8B | $48M |
|---|---|---|
| Total debt | $51.6B | $34.6B |
| Net debt / EBITDA | 5.6 | 7.5 |
| Interest cover | 2.4× | 1.3× |
| Dividend yield | 3.7% | 3.4% |
|---|---|---|
| Dividend per share, 12 months | $1.66 | $2.62 |
| Dividend growth a year, past | +0.9%over 5 years | +4.3%over 5 years |
| Buyback yield | – | 0.1% |
| Shareholder yield | 3.7% | 3.6% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, DBA Sempra ($49.8B) is about 1.1 times Exelon ($46.5B), at today's prices.
Since November 21, 2016, EXC's price moved +96.0% and SRE's +53.0%. With dividends: EXC +175.8% (+10.7% a year), SRE +109.6% (+7.7% a year). Past returns do not predict future ones.
The dividend yield at today's price is 3.65% for Exelon and 3.43% for DBA Sempra. Over the last twelve months they paid $1.66 and $2.62 per share.
At today's price, the P/E is 16.7 for EXC and 22.0 for SRE. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 11.0% for Exelon and 18.3% for DBA Sempra, and the operating margin 20.8% and –. Revenue was $25.3B and $12.5B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.